| Application no. and date | 04741403.2 (espacenet) (Federated) (European Patent Register), 20040809 | | Patent/reg. no. and date | DK/EP 1663191, 20100120 | | Publication date | 20060607 | | Priority no. and date | GB 0318824, 20030811 | | EP pub. no. and date |
EP 1663191 20060607 | | Effective date | | | Applicant/owner | SmithKline Beecham (Cork) Limited, Currabinny
Carrigaline
Cork, IE | | Applicant ref. no. | P81000768DK00E | | Inventor | COLES, Peter John,
GlaxoSmithKline Inc., 7333 Mississauga Road North
Mississauga, Ontario L5N 6L4, CA,
MUDD, Paul Norman, Jr.,
GlaxoSmithKline, Five Moore Drive
Research Triangle Park, NC 27709, US,
MACKENZIE, Donald Colin,
GlaxoSmithKline (CIDRA), 709 Swedeland Road ,
King of Prussia
Pennsylvania 19406, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/155 (2006.01) , A61K 31/4439 (2006.01) , A61K 9/28 (2006.01) , A61P 3/10 (2006.01) | | Title | Sammensætning omfattende rosiglitazon og metformin | | Int. application no. | EP2004008970 | | Int. publication no. | WO2005013956 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
